| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697554 | Cancer Treatment Reviews | 2017 | 7 Pages |
Abstract
Extended treatment with AIs is associated with similar relative improvements in DFS in all subgroups analyzed. The combination of greater effect size and higher absolute risk of recurrence in node positive and larger tumors will likely translate to higher absolute benefits from extended AIs in these groups.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hadar Goldvaser, Ibrahim AlGorashi, Domen Ribnikar, Bostjan Seruga, Arnoud J. Templeton, Alberto Ocana, Eitan Amir,